Vers l'imagerie in vivo de l'alpha-synucléine.

Vers l'imagerie in vivo de l'alpha-synucléine.

Les maladies neurodégénératives sont un sujet de santé publique majeur. La maladie de Parkinson (MP), la démence à corps de Lewy (DCL) et l'atrophie multisystématisée (AMS) font partie d'une famille liées à l'accumulation pathologique d'une protéine : l'α-synucléine (α-syn),...

Full description

Bibliographic Details
Main Author:	Levigoureux, Elise
Other Authors:	Lyon 1
Language:	fr
Published:	2015
Subjects:	Imagerie TEP Synucléinopathies Modèle animal Système sérotoninergique PET imaging Synucleinopathies Animal model Serotonin system 612.8
Online Access:	http://www.theses.fr/2015LYO10313/document

Similar Items

Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
by: Rachael H. Earls, et al.
Published: (2019-12-01)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
by: Megan F. Duffy, et al.
Published: (2018-05-01)

Alpha-synuclein in cutaneous small nerve fibers
by: Siepmann T, et al.
Published: (2016-10-01)

A New Rise of Non-Human Primate Models of Synucleinopathies
by: Margaux Teil, et al.
Published: (2021-03-01)

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
by: Špela Korat, et al.
Published: (2021-08-01)

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
by: Joseph R. Patterson, et al.
Published: (2019-10-01)

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
by: Maxime WC Rousseaux, et al.
Published: (2016-10-01)

The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
by: Katja Malfertheiner, et al.
Published: (2021-10-01)

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease
by: Eileen Ruth S. Torres, et al.
Published: (2021-10-01)

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
by: Veronica Ghiglieri, et al.
Published: (2018-05-01)

Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells
by: Jinar Rostami, et al.
Published: (2020-11-01)

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
by: Francesca Longhena, et al.
Published: (2019-01-01)

Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
by: Luis D. Bernal-Conde, et al.
Published: (2020-01-01)

The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
by: David I. Finkelstein, et al.
Published: (2017-06-01)

Approches multifactorielles et translationnelles dans la modélisation des synucléinopathies : implications mécanistiques et thérapeutiques
by: Arotcarena, Marie-Laure
Published: (2019)

Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
by: Penelope J. Hallett, et al.
Published: (2012-08-01)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
by: Kensuke Ikenaka, et al.
Published: (2019-07-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)

Mechanism of Anti-α-Synuclein Immunotherapy
by: Jun Sung Lee, et al.
Published: (2016-01-01)

Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity
by: Sortwell, C.E, et al.
Published: (2022)

Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study
by: Lu-Lu Bu, et al.
Published: (2020-11-01)

Editorial: Intracellular Mechanisms of α-Synuclein Processing
by: Friederike Zunke, et al.
Published: (2021-09-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
by: Antonio Heras-Garvin, et al.
Published: (2020-09-01)

Import and Export of Misfolded α-Synuclein
by: Lilia Rodriguez, et al.
Published: (2018-05-01)

La tomographie à émission de positrons à géométrie axiale : de l’imagerie de la souris au cerveau humain
by: Brard, Emmanuel
Published: (2013)

A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
by: Karima Schwab, et al.
Published: (2018-01-01)

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
by: Jacqui T. Nimmo, et al.
Published: (2020-11-01)

Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
by: Cathryn L. Ugalde, et al.
Published: (2020-01-01)

Precision and False Perceptual Inference
by: Thomas Parr, et al.
Published: (2018-09-01)

Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)

Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
by: Lasse Reimer, et al.
Published: (2018-07-01)

Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson’s disease A53T mouse model
by: Alicia Flores-Cuadrado, et al.
Published: (2019-04-01)

Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration
by: Javier María Peralta Ramos, et al.
Published: (2019-01-01)

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques
by: Diego Sucunza, et al.
Published: (2021-05-01)

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
by: Niccolo Candelise, et al.
Published: (2020-01-01)

A cell culture model for monitoring α-synuclein cell-to-cell transfer
by: Juan F. Reyes, et al.
Published: (2015-05-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: Attems, J., et al.
Published: (2022)

Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy
by: Alessandra Bigi, et al.
Published: (2021-05-01)